Cumberland Pharmaceuticals (CPIX) Enterprise Value (2016 - 2025)
Historic Enterprise Value for Cumberland Pharmaceuticals (CPIX) over the last 17 years, with Q3 2025 value amounting to -$15.5 million.
- Cumberland Pharmaceuticals' Enterprise Value rose 1270.67% to -$15.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$15.5 million, marking a year-over-year increase of 1270.67%. This contributed to the annual value of -$18.3 million for FY2024, which is 210.82% up from last year.
- According to the latest figures from Q3 2025, Cumberland Pharmaceuticals' Enterprise Value is -$15.5 million, which was up 1270.67% from -$16.4 million recorded in Q2 2025.
- Over the past 5 years, Cumberland Pharmaceuticals' Enterprise Value peaked at -$15.4 million during Q1 2025, and registered a low of -$27.3 million during Q4 2021.
- In the last 5 years, Cumberland Pharmaceuticals' Enterprise Value had a median value of -$18.6 million in 2023 and averaged -$19.6 million.
- Its Enterprise Value has fluctuated over the past 5 years, first skyrocketed by 3018.85% in 2022, then tumbled by 1287.61% in 2024.
- Over the past 5 years, Cumberland Pharmaceuticals' Enterprise Value (Quarter) stood at -$27.3 million in 2021, then rose by 26.43% to -$20.1 million in 2022, then increased by 6.91% to -$18.7 million in 2023, then increased by 2.11% to -$18.3 million in 2024, then rose by 15.08% to -$15.5 million in 2025.
- Its Enterprise Value was -$15.5 million in Q3 2025, compared to -$16.4 million in Q2 2025 and -$15.4 million in Q1 2025.